Bristol-Myers Squibb to Build New Jersey Facility

Sep 24, 2014

Bristol-Myers Squibb Company plans to build a 650,000-square-foot office building on company-owned land in Lawrenceville, New Jersey. Construction is expected to begin this fall and the new facility is expected to open by the end of 2016.

The new facility is part of the company’s broader strategic plan to modernize its workspace to enable greater collaboration, increase technological capabilities and enhance productivity, according to a press release. The new facility will allow the company to consolidate operations currently located in leased office space.

“We are proud to expand our presence in Lawrenceville, a community that has been home to our company for more than 40 years,” says chief executive officer Lamberto Andreotti. “Our new campus will create a dynamic and modern workplace to advance the important work that our employees are doing to discover, develop and deliver innovative medicines for patients with serious diseases.”

The new campus will be the company’s second in Lawrence Township, joining its worldwide headquarters, which opened in 1971. The company currently employs more than 2,000 people at the Route 206 campus and more than 6,000 in Central New Jersey. Once completed, as many as 2,500 people will work at the new facility. Read the full release